Fundraising Fox
TreeFrog Therapeutics
Bordeaux, FR · Founded 2018 · 158 employees on LinkedIn · 1 known investors
Find your way into TreeFrog Therapeutics
Sign up to see every warm intro you have to TreeFrog Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the TreeFrog Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
TreeFrog develops C-Stem, a GMP-compliant technology platform for scalable production of cell therapies that optimizes yield and quality while minimizing cell damage. The platform serves biotech and cell therapy companies from early-stage research through commercial manufacturing.
Investors · 1
AQUITI Gestionlisted by AQUITI GestionBordeaux
How we know: AQUITI Gestion's portfolio page · funding news · Not right? Tell us
Funding
SEC filings, press & company announcements$75M disclosed across 1 round · 2021
- $75MSeries BSep 2021 · 3 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does TreeFrog Therapeutics do?
- TreeFrog develops C-Stem, a GMP-compliant technology platform for scalable production of cell therapies that optimizes yield and quality while minimizing cell damage. The platform serves biotech and cell therapy companies from early-stage research through commercial manufacturing.
- Who are TreeFrog Therapeutics's investors?
- TreeFrog Therapeutics's investors include AQUITI Gestion.
- How much funding has TreeFrog Therapeutics raised?
- TreeFrog Therapeutics has disclosed $75M raised across 1 round.
- Where is TreeFrog Therapeutics headquartered?
- TreeFrog Therapeutics is headquartered in Bordeaux, FR.